For instance, mutations in the BRCA1 and BRCA2 genes are strongly associated with an increased risk of breast and ovarian cancers, and genetic testing for BRCA1 and BRCA2 mutations help identify individuals at high risk.55 This evidence concerns the gene BRCA1 and ovarian carcinoma.